ACG Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$680K Sell
5,818
-24
-0.4% -$2.81K 0.16% 143
2022
Q2
$687K Hold
5,842
0.14% 150
2022
Q1
$761K Sell
5,842
-683
-10% -$89K 0.14% 148
2021
Q4
$996K Buy
6,525
+1,013
+18% +$155K 0.14% 148
2021
Q3
$891K Sell
5,512
-202
-4% -$32.7K 0.12% 149
2021
Q2
$935K Sell
5,714
-6,885
-55% -$1.13M 0.12% 145
2021
Q1
$1.9M Buy
12,599
+58
+0.5% +$8.73K 0.25% 85
2020
Q4
$1.9M Buy
12,541
+40
+0.3% +$6.06K 0.26% 82
2020
Q3
$1.69M Buy
12,501
+4,216
+51% +$571K 0.26% 79
2020
Q2
$1.13M Buy
8,285
+4,690
+130% +$641K 0.18% 103
2020
Q1
$387K Buy
3,595
+215
+6% +$23.1K 0.07% 207
2019
Q4
$407K Sell
3,380
-611
-15% -$73.6K 0.06% 233
2019
Q3
$397K Sell
3,991
-400
-9% -$39.8K 0.06% 235
2019
Q2
$479K Sell
4,391
-45
-1% -$4.91K 0.06% 221
2019
Q1
$496K Buy
4,436
+10
+0.2% +$1.12K 0.07% 206
2018
Q4
$427K Sell
4,426
-620
-12% -$59.8K 0.07% 199
2018
Q3
$615K Buy
5,046
+200
+4% +$24.4K 0.08% 172
2018
Q2
$532K Sell
4,846
-163
-3% -$17.9K 0.08% 166
2018
Q1
$535K Sell
5,009
-145
-3% -$15.5K 0.08% 176
2017
Q4
$550K Sell
5,154
-240
-4% -$25.6K 0.08% 186
2017
Q3
$600K Sell
5,394
-222
-4% -$24.7K 0.1% 152
2017
Q2
$581K Sell
5,616
-216
-4% -$22.3K 0.1% 178
2017
Q1
$570K Buy
5,832
+108
+2% +$10.6K 0.1% 158
2016
Q4
$506K Buy
5,724
+240
+4% +$21.2K 0.11% 147
2016
Q3
$529K Hold
5,484
0.11% 147
2016
Q2
$470K Sell
5,484
-36
-0.7% -$3.09K 0.1% 144
2016
Q1
$480K Hold
5,520
0.11% 139
2015
Q4
$623K Buy
5,520
+654
+13% +$73.8K 0.14% 121
2015
Q3
$492K Sell
4,866
-720
-13% -$72.8K 0.13% 120
2015
Q2
$687K Sell
5,586
-684
-11% -$84.1K 0.17% 107
2015
Q1
$718K Sell
6,270
-45
-0.7% -$5.15K 0.19% 104
2014
Q4
$639K Sell
6,315
-210
-3% -$21.2K 0.17% 109
2014
Q3
$595K Sell
6,525
-2,466
-27% -$225K 0.17% 111
2014
Q2
$770K Buy
8,991
+1,488
+20% +$127K 0.15% 108
2014
Q1
$591K Buy
7,503
+168
+2% +$13.2K 0.18% 107
2013
Q4
$555K Buy
+7,335
New +$555K 0.14% 107
2013
Q3
Sell
-7,809
Closed -$453K 115
2013
Q2
$453K Buy
+7,809
New +$453K 0.18% 93